These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 29770133)

  • 81. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
    Kröger N; Renges H; Krüger W; Gutensohn K; Löliger C; Carrero I; Cortes L; Zander AR
    Br J Haematol; 2000 Dec; 111(3):761-5. PubMed ID: 11122135
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [CD34 cells and T cell subsets in recombinant human granulocyte colony-stimulating factor primed bone marrow grafts from donors with different characteristics].
    Chang YJ; Zhao XY; Huo MR; Luo XH; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):512-6. PubMed ID: 19112912
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
    Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
    Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Comparative analysis of naive and memory CD4(+) and CD8(+) T-cell subsets in rhG-CSF mobilized peripheral blood and steady-state bone marrow].
    Huo MR; Zhao XY; Chang YJ; Luo XH; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):605-9. PubMed ID: 18549638
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH; Schulman KA; Buckner CD
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts.
    Rutella S; Filippini P; Bertaina V; Li Pira G; Altomare L; Ceccarelli S; Brescia LP; Lucarelli B; Girolami E; Conflitti G; Cefalo MG; Bertaina A; Corsetti T; Moretta L; Locatelli F
    J Transl Med; 2014 Sep; 12():240. PubMed ID: 25179788
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
    Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
    Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.
    Arpinati M; Green CL; Heimfeld S; Heuser JE; Anasetti C
    Blood; 2000 Apr; 95(8):2484-90. PubMed ID: 10753825
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor.
    Condomines M; Quittet P; Lu ZY; Nadal L; Latry P; Lopez E; Baudard M; Requirand G; Duperray C; Schved JF; Rossi JF; Tarte K; Klein B
    J Immunol; 2006 Jun; 176(11):6631-9. PubMed ID: 16709821
    [TBL] [Abstract][Full Text] [Related]  

  • 91. No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF.
    Gazitt Y; Akay C; Thomas C
    Stem Cells Dev; 2006 Apr; 15(2):269-77. PubMed ID: 16646673
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
    Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
    Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Impact of donor hematopoietic cells mobilized with G-CSF and plerixafor on murine acute graft-versus-host-disease.
    Arbez J; Saas P; Lamarthée B; Malard F; Couturier M; Mohty M; Gaugler B
    Cytotherapy; 2015 Jul; 17(7):948-55. PubMed ID: 25813681
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation.
    Gürman G; Dilek I; Arslan O; Arat M; Beksaç M; Ilhan O; Ozcan M; Akan H; Dalva K; Konuk N; Uysal A; Koç H
    Transfus Apher Sci; 2001 Feb; 24(1):23-8. PubMed ID: 11515607
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients.
    Joshi SS; Miller K; Jackson JD; Warkentin P; Kessinger A
    Cytotherapy; 2000; 2(1):15-24. PubMed ID: 12042051
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression.
    Rutella S; Rumi C; Pierelli L; Morosetti R; Sica S; Bonanno G; Scambia G; Leone G
    Exp Hematol; 2000 Jun; 28(6):612-25. PubMed ID: 10880747
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation.
    Waller EK; Logan BR; Fei M; Lee SJ; Confer D; Howard A; Chandrakasan S; Anasetti C; Fernando SM; Giver CR
    Blood Adv; 2019 Aug; 3(15):2250-2263. PubMed ID: 31345792
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Allogeneic Peripheral Blood Stem Cell Transplant: Correlation of Donor Factors with Yield, Engraftment, Chimerism, and Outcome: Retrospective Review of a Single Institute During a 3-Year Period.
    Philip J; Bajaj AK; Sharma S; Kushwaha N; Kumar S; Kumar Biswas A
    Lab Med; 2020 Jul; 51(4):362-369. PubMed ID: 31758694
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?
    Morris ES; MacDonald KP; Hill GR
    Blood; 2006 May; 107(9):3430-5. PubMed ID: 16380448
    [TBL] [Abstract][Full Text] [Related]  

  • 100. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient.
    Reddy V; Hill GR; Pan L; Gerbitz A; Teshima T; Brinson Y; Ferrara JL
    Transplantation; 2000 Feb; 69(4):691-3. PubMed ID: 10708136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.